Meeting
2018 Gastrointestinal Cancers Symposium
Metastatic colorectal cancer (mCRC) treatment patterns in the Medicare population.
Authors
Jeremy Snider
Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ
Jeremy Snider , Ed Wang , Sibyl Anderson , Jordan Steelquist , Greg S Warnick , Catherine R. Fedorenko , Veena Shankaran , Scott David Ramsey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 823)
DOI
10.1200/JCO.2018.36.4_suppl.823
Abstract #
823
Poster Bd #
M22
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Quality Care Symposium
Treatment patterns of patients with metastatic colorectal cancer in a large national U.S. claims-based data.
First Author: Yue Zhong
Poster
2014 Gastrointestinal Cancers Symposium
Cost differential among systemic therapies for colon cancer.
First Author: Hasan Nadeem
Poster
2016 Gastrointestinal Cancers Symposium
Treatment patterns and outcomes in patients with KRAS wild type (WT) metastatic colorectal cancer (mCRC) treated in first line with bevacizumab (B) or cetuximab (C) containing regimens.
First Author: Arthur C. Houts
Poster
2012 Gastrointestinal Cancers Symposium
Comparative effectiveness of treatment options in elderly patients with colon cancer receiving adjuvant chemotherapy.
First Author: Sacha Satram-Hoang